Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for MEDANTA.BO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MEDANTA.BO and 80,000+ other tickers.
See exactly how MEDANTA.BO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MEDANTA.BO and 80,000+ other tickers.
Operating within India, Global Health Limited delivers a comprehensive range of medical services. Its extensive portfolio encompasses crucial areas such as organ transplantation (including lung and liver), maternal and pediatric care, neonatology, and specialized oncology services like URO-oncology, surgical, and radiation oncology. The company also provides expertise in fields like pulmonology, orthopaedics, urology, endocrine surgery, gastroenterology, psychiatry, and ENT, alongside essential blood bank and chest care provisions. Further expanding its offerings, it addresses digestive and…
No recent news available.